133 related articles for article (PubMed ID: 9797033)
1. Peripheral component in the enhanced antinociceptive effect of systemic U-69,593, a kappa-opioid receptor agonist in mononeuropathic rats.
Catheline G; Guilbaud G; Kayser V
Eur J Pharmacol; 1998 Sep; 357(2-3):171-8. PubMed ID: 9797033
[TBL] [Abstract][Full Text] [Related]
2. Further evidence for a peripheral component in the enhanced antinociceptive effect of systemic morphine in mononeuropathic rats: involvement of kappa-, but not delta-opioid receptors.
Catheline G; Kayser V; Guilbaud G
Eur J Pharmacol; 1996 Nov; 315(2):135-43. PubMed ID: 8960876
[TBL] [Abstract][Full Text] [Related]
3. Antinociceptive effect of a kappa-opioid receptor agonist that minimally crosses the blood-brain barrier (ICI 204448) in a rat model of mononeuropathy.
Keïta H; Kayser V; Guilbaud G
Eur J Pharmacol; 1995 Apr; 277(2-3):275-80. PubMed ID: 7493620
[TBL] [Abstract][Full Text] [Related]
4. Effects of U-69,593, a kappa-opioid receptor agonist, on carrageenin-induced peripheral oedema and Fos expression in the rat spinal cord.
Catheline G; Le Guen S; Besson JM
Eur J Pharmacol; 1999 Apr; 370(3):287-96. PubMed ID: 10334505
[TBL] [Abstract][Full Text] [Related]
5. The antinociceptive activity of kappa- but not delta-opioid receptor agonists is maintained in morphine-tolerant neuropathic rats.
Catheline G; Kayser V; Idänpään-Heikkilä JJ; Guilbaud G
Eur J Pharmacol; 1996 Dec; 318(2-3):273-81. PubMed ID: 9016915
[TBL] [Abstract][Full Text] [Related]
6. Analgesic and antiinflammatory effects of two novel kappa-opioid peptides.
Binder W; Machelska H; Mousa S; Schmitt T; Rivière PJ; Junien JL; Stein C; Schäfer M
Anesthesiology; 2001 Jun; 94(6):1034-44. PubMed ID: 11465595
[TBL] [Abstract][Full Text] [Related]
7. ATP-gated K(+) channel openers enhance opioid antinociception: indirect evidence for the release of endogenous opioid peptides.
Lohmann AB; Welch SP
Eur J Pharmacol; 1999 Dec; 385(2-3):119-27. PubMed ID: 10607867
[TBL] [Abstract][Full Text] [Related]
8. Evidence that nor-binaltorphimine can function as an antagonist at multiple opioid receptor subtypes.
Spanagel R; Almeida OF; Shippenberg TS
Eur J Pharmacol; 1994 Oct; 264(2):157-62. PubMed ID: 7851478
[TBL] [Abstract][Full Text] [Related]
9. Effects of opioid receptor antagonists on the effects of i.v. morphine on carrageenin evoked c-Fos expression in the superficial dorsal horn of the rat spinal cord.
Catheline G; Le Guen S; Besson JM
Brain Res; 1999 Apr; 824(1):105-11. PubMed ID: 10095048
[TBL] [Abstract][Full Text] [Related]
10. Peripheral kappa-opioid receptors mediate the antinociceptive effect of fedotozine (correction of fetodozine) on the duodenal pain reflex inrat.
Diop L; Rivière PJ; Pascaud X; Junien JL
Eur J Pharmacol; 1994 Dec; 271(1):65-71. PubMed ID: 7698213
[TBL] [Abstract][Full Text] [Related]
11. Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues.
Gouardères C; Jhamandas K; Sutak M; Zajac JM
Br J Pharmacol; 1996 Feb; 117(3):493-501. PubMed ID: 8821539
[TBL] [Abstract][Full Text] [Related]
12. Opioid antagonist profile of SC nor-binaltorphimine in the formalin paw assay.
Wettstein JG; Grouhel A
Pharmacol Biochem Behav; 1996 Feb; 53(2):411-6. PubMed ID: 8808151
[TBL] [Abstract][Full Text] [Related]
13. Lack of cross-tolerance between the antinociceptive effects of systemic morphine and asimadoline, a peripherally-selective kappa-opioid agonist, in CCI-neuropathic rats.
Walker J; Catheline G; Guilbaud G; Kayser V
Pain; 1999 Dec; 83(3):509-516. PubMed ID: 10568859
[TBL] [Abstract][Full Text] [Related]
14. Selective opioid receptor agonists modulate mechanical allodynia in an animal model of neuropathic pain.
Desmeules JA; Kayser V; Guilbaud G
Pain; 1993 Jun; 53(3):277-285. PubMed ID: 8394563
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of tolerance to spinal morphine antinociception by low doses of opioid receptor antagonists.
McNaull B; Trang T; Sutak M; Jhamandas K
Eur J Pharmacol; 2007 Apr; 560(2-3):132-41. PubMed ID: 17307158
[TBL] [Abstract][Full Text] [Related]
16. Antinociceptive effect of systemic kelatorphan, in mononeuropathic rats, involves different opioid receptor types.
Lee SH; Kayser V; Guilbaud G
Eur J Pharmacol; 1994 Oct; 264(1):61-7. PubMed ID: 7828644
[TBL] [Abstract][Full Text] [Related]
17. The antihyperalgesic effect of docosahexaenoic acid in streptozotocin-induced neuropathic pain in the rat involves the opioidergic system.
Landa-Juárez AY; Pérez-Severiano F; Castañeda-Hernández G; Ortiz MI; Chávez-Piña AE
Eur J Pharmacol; 2019 Feb; 845():32-39. PubMed ID: 30582909
[TBL] [Abstract][Full Text] [Related]
18. Spinal effect of a neuropeptide FF analogue on hyperalgesia and morphine-induced analgesia in mononeuropathic and diabetic rats.
Courteix C; Coudoré-Civiale MA; Privat AM; Zajac JM; Eschalier A; Fialip J
Br J Pharmacol; 1999 Jul; 127(6):1454-62. PubMed ID: 10455296
[TBL] [Abstract][Full Text] [Related]
19. Intramuscular administration of morphine reduces mustard-oil-induced craniofacial-muscle pain behavior in lightly anesthetized rats.
Han SR; Lee MK; Lim KH; Yang GY; Jeon HJ; Ju JS; Yoon YW; Kim SK; Ahn DK
Eur J Pain; 2008 Apr; 12(3):361-70. PubMed ID: 17768078
[TBL] [Abstract][Full Text] [Related]
20. Place aversion induced by blockade of mu or activation of kappa opioid receptors in the dorsal periaqueductal gray matter.
Sante AB; Nobre MJ; Brandão ML
Behav Pharmacol; 2000 Nov; 11(7-8):583-9. PubMed ID: 11198129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
